Application of ET-Kyoto solution in clinical lung transplantation.
We have developed a new organ preservation solution called extracellular-type trehalose-containing Kyoto (ET-Kyoto) solution. ET-Kyoto solution has been applied in clinical lung transplantation. The patient was a 49-year-old woman with diffuse panbronchiolitis. She underwent bilateral lobar lung transplantation from living donors. Each lobe was flushed with ET-Kyoto solution. After reperfusion, PaO(2) with inhalation of 100% oxygen was more than 500 Torr. Posttransplantation course was uneventful. Despite the relatively short ischemic time of this case report, ET-Kyoto solution may be feasible and safely applied in clinical lung transplantation.
Omasa
Mitsugu
M
Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.
Hasegawa
Seiki
S
Bando
Toru
T
Hanaoka
Nobuharu
N
Yoshimura
Takashi
T
Nakamura
Takayuki
T
Wada
Hiromi
H
D005260:Female; D005942:Gluconates; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D016040:Lung Transplantation; D008875:Middle Aged; D019188:Organ Preservation Solutions; D010710:Phosphates; D014199:Trehalose
C087059:ET-Kyoto solution; D005942:Gluconates; D006895:Hydroxyethyl Starch Derivatives; D019188:Organ Preservation Solutions; D010710:Phosphates; D014199:Trehalose